RMD RMD レスメド

 RMDのチャート


 RMDの企業情報

symbol RMD
会社名 ResMed Inc. (RMD レスメド)
分野(sector)   
産業(industry)   
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 レスメド(ResMed Inc.)は持株会社である。同社は睡眠呼吸障害(SDB)、慢性閉塞性肺疾患(COPD)、神経筋疾患および呼吸器疾患を診断、治療および管理する医療機器およびクラウドベースのソフトウェアアプリケーションの開発、製造、流通および販売に従事する。SDBには、閉塞性睡眠時無呼吸(OSA)および睡眠中に生じる他の呼吸器障害が含まれる。クラウドベースのソフトウェアデジタルヘルスアプリケーションとその機器は患者のアウトカムを改善するために接続されたケアを提供するように設計される。同社の製品ポートフォリオには、機器、診断製品、マスクシステム、ヘッドギアおよびその他のアクセサリ、歯科用デバイス、ポータブル酸素濃縮器(POC)、クラウドベースのソフトウェアインフォマティクスソリューションが含まれる。同社はSDBの治療のための継続的陽性気道内圧(CPAP)、可変陽性気道内圧(VPAP)およびAutoSetシステムを製造する。  レスメドは米国の医療機器メ―カ―持株会社。子会社を通じ、睡眠呼吸障害(SDB)およびその他の呼吸器疾患を治療、診断、管理するための医療機器を開発、製造、販売。SDBは閉塞性睡眠時無呼吸(OSA)、および睡眠中に発生する他の呼吸器障害を含む。気流発生装置、診断製品、マスクシステム、ヘッドギアやその他の付属品などを取り扱う。本社はサンディエゴ。  ResMed pioneers innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Its comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, the company improves quality of life, reduces the impact of chronic disease, and lowers costs for consumers and healthcare systems in more than 140 countries.
本社所在地 9001 Spectrum Center Blvd. San Diego CA 92123 USA
代表者氏名 Robert Andrew Douglas
代表者役職名 President Chief Operating Officer
電話番号 +1 858-746-2400
設立年月日 34394
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 5940人
url www.resmed.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 748.78800
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 14898.90000
売上高 売上高(百万ドル) 2454.64300
企業価値(EV) 企業価値(EV)(百万ドル) 15946.91000
当期純利益 当期純利益(百万ドル) 462.88200
決算概要 決算概要 BRIEF: For the six months ended 31 December 2018 ResMed Inc. revenues increased 10% to $1.24B. Net income before extraordinary items increased 4% to $231.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Selling general and administrative increase of 4% to $308.9M (expense) Interest income decrease of 83% to $1.6M (income).

 RMDのテクニカル分析


 RMDのニュース

   Positive Airway Pressure Devices Global Market Report 2022  2022/05/25 08:19:00 GlobeNewswire
Major players in the positive airway pressure devices market are ResMed Inc, Koninklijke Philips N. V, 3B Medical Inc, Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare LLC, Somnetics International Inc, Heyer Medical, Genstar Technologies, BMC Medical, and Apex Medical. Major players in the positive airway pressure devices market are ResMed Inc, Koninklijke Philips N. V, 3B Medical Inc, Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare LLC, Somnetics International Inc, Heyer Medical, Genstar Technologies, BMC Medical, and Apex Medical.
   Respiratory Devices And Equipment (Therapeutic And Diagnostic) Global Market Report 2022  2022/05/13 11:49:00 GlobeNewswire
Major players in the respiratory devices and equipment market are Smiths Medical, Philips Healthcare, GE Healthcare, Chart Industries, Invacare Corporation, Fisher & Paykel Healthcare Limited, ResMed, Dragerwerk AG, Medtronic plc, Masimo corp. Major players in the respiratory devices and equipment market are Smiths Medical, Philips Healthcare, GE Healthcare, Chart Industries, Invacare Corporation, Fisher & Paykel Healthcare Limited, ResMed, Dragerwerk AG, Medtronic plc, Masimo corp.
   Respiratory Disposables Global Market Report 2022  2022/05/13 08:49:00 GlobeNewswire
Major players in the respiratory disposables market are Fisher & Paykel, Becton Dickinson Company, Ambu A/S, Smiths Medical, Armstrong Medical, Teleflex, Philips Respironics, Besmed, ResMed, and Dynarex. Major players in the respiratory disposables market are Fisher & Paykel, Becton Dickinson Company, Ambu A/S, Smiths Medical, Armstrong Medical, Teleflex, Philips Respironics, Besmed, ResMed, and Dynarex.
   ResMed''s Q3 Earnings Short Of Expectations, Profit Margins Contract  2022/04/29 11:50:40 Benzinga
ResMed Inc''s (NYSE: RMD ) Q3 FY22 sales increased by 12% Y/Y (+14% on a constant currency basis) to $864.5 million, missing the consensus of $897 million. The revenue growth was driven by increased demand for sleep and respiratory care devices and an increased demand following an ongoing recall of rival Koninklijke Philips N.V. (NYSE: PHG ) products. ResMed generated $35 … Full story available on Benzinga.com
   Insights on the Medical Oxygen Concentrators Global Market to 2028 - Featuring Invacare, ResMed and Precision Medical Among Others  2022/04/28 21:30:00 Kwhen Finance
   Global Positive Airway Pressure Markets 2022-2027 with Koninklijke Philips, ResMed, Smiths Group, 3B Medical, and Apex Medical Dominating - ResearchAndMarkets.com  2022/03/30 13:15:00 Kwhen Finance
   ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference  2022/03/10 14:00:00 GlobeNewswire
SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 32 nd Annual Healthcare Conference on Tuesday, March 15, 2022, beginning at approximately 1:20 p.m. (Eastern Daylight Time) via webcast.
   2 of the best ASX healthcare shares to buy now according to analysts  2022/03/09 22:33:39 The Motley Fool Australia
ResMed Inc (ASX:RMD) and this ASX healthcare share could be top options in the sector right now. Here''s what you need to know…
   ResMed Inc. – Consensus Indicates Potential 7.2% Upside  2022/03/05 15:31:34 DirectorsTalk
ResMed Inc. found using ticker (RMD) now have 5 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 312 and 235 calculating the mean target price we have 268. With the stocks previous close at 249.91 this now indicates there is a potential upside of 7.2%. There is a 50 day moving average of 243 and the 200 day MA is 254.1. The market capitalisation for the company is $37,231m. You can visit the company''s website by visiting: https://www.resmed.com [stock_market_widget type="chart" template="basic" color="green" assets=RMD" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $39,926m based on the market concensus. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service.
   IHI: A Standout Performer With Equally Strong Future Growth Prospects  2022/03/05 05:42:51 Kwhen Finance
   Actigraphy Sensors & PSG Devices Market to reach USD 1.4 billion by 2027 | Resmed, Somno medics, Cidelec, Nox medicals  2021/10/04 19:05:00 iCrowdNewswire
Global Actigraphy Sensors & PSG Devices Market Size study, By Product Type (Actigraphy Devices, Polysomnography Devices), By Technology (Wireless USB GPS Others) and Regional Forecasts 2021-2027, The Actigraphy Sensors & PSG Devices market research report added by Report Ocean, []
   Nursing Homes and Long-Term Care Facilities Market to Eyewitness Massive Growth by 2027 | Top Key Players Allscripts, Cerner, CVS Health, Omnicell, ResMed, McKesson, MatrixCare  2021/10/04 11:18:57 OpenPR
Overview of Global Nursing Homes and Long-Term Care Facilities Market: Todays businesses choose the market research report solution such as Nursing Homes and Long-Term Care Facilities Market report because it lends a hand with the improved decision making and more revenue
   ICU Devices Market Trending Technologies, Remarkable Developments and Key Players like GE, BD, Baxter, Stryker, ResMed, Siemens, ICU Medical | Foreseen Till 2027  2021/09/29 13:44:52 OpenPR
Overview of Global ICU Devices Market: The Global ICU Devices Market report is a skilful and deep analysis of the present situation and challenges. This report focuses on the key drivers, restraints, Market opportunities, threats and risks for Market major players.
   Sleep Apnea Devices Market Size 2021 Demand, Business strategy, Statistics and Research Methodology ||Philips Healthcare, Lowenstein Medical Technology, ResMed, Philips Healthcare, Carefusion||  2021/09/29 10:11:27 OpenPR
The information made available in the Sleep Apnea Devices report will definitely facilitate to increase the knowledge and decision-making skills of the business, thus providing an immense opportunity for growth. This will at last increase the return rate and
   Top broker says ResMed (ASX:RMD) share price is a buy  2021/09/28 21:14:36 The Motley Fool Australia
This sleep treatment company''s shares could be in the buy zone The post Top broker says ResMed (ASX:RMD) share price is a buy appeared first on The Motley Fool Australia .

 関連キーワード  (先端医療機器_テクノロジ― 米国株 RMD レスメド RMD )

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)